NextDocs snaps up $13.5 million in financing; Accelrys announces latest releases;

> An EU-backed project aims to use imaging and bioinformatics to understand the role of lipid metabolism in psychotic disorders. Article

> Accelrys ($ACCL) pledges to boost productivity in biotech research with the latest releases of its Direct, Chemical Registration and Biological Registration applications. Release

> Physicians have a lot of influence over which pharma websites patients visit, according to a study. Article

> SeaChange Pharmaceuticals has released software for matching drugs with disease targets based on multiple variables. Item

> NextDocs, a provider of content management software for life sciences groups, has reeled in $13.5 million in new financing. Article